About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
KUMC Updated Data on mCRPC: Cabazitaxel vs. Abiraterone/Enzalutamide, Lu-177 vs. Cabazitaxel, Olaparib vs. Enzalutamide/Abiraterone, Rucaparib for BRCA Alterations
By
2021 KUMC Virtual Multidisciplinary Oncology Review
FEATURING
Rahul Parikh
By
2021 KUMC Virtual Multidisciplinary Oncology Review
FEATURING
Rahul Parikh
18 views
May 17, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
2021 KUMC Virtual Multidisciplinary Oncology Review
06:40
2021 KUMC Virtual Multidisciplinary Oncology Review
IO/Chemo Developments in Advanced GE/GEJ Cancer: 1L Nivo/Pembro, Per…
Feat.
A. Saeed
05:28
2021 KUMC Virtual Multidisciplinary Oncology Review
IO+VEGF TKI Developments in Advanced GE/GEJ Cancer: Overview of Clin…
Feat.
A. Saeed
09:20
2021 KUMC Virtual Multidisciplinary Oncology Review
Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bem…
Feat.
A. Saeed
20:29
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates in Musculoskeletal Oncologic Surgery: Pros and Cons, Custom …
Feat.
K. Sweeney
22:15
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Sarcoma Updates: Surgery in Extremity Sarcomas, Chemo/XRT for S…
Feat.
B. Powers
11:11
2021 KUMC Virtual Multidisciplinary Oncology Review
TaTME in Colon and Rectal Surgery: Comparison to Robotic & Lapar…
Feat.
V. Obias
18:04
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Updates on Robotics in Colorectal Surgery: Flexrobotic System f…
Feat.
V. Obias
22:43
2021 KUMC Virtual Multidisciplinary Oncology Review
Recent Changes in Surgical Management of CRC: Colon Cancer Triage, O…
Feat.
S. Luka
18:39
2021 KUMC Virtual Multidisciplinary Oncology Review
Interventional Oncology for Colorectal Metastases: Percutaneous Ther…
Feat.
A. Alli
17:05
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Advances in Neoadjuvant/Adjuvant Therapy for CRC: TNT for LARC,…
Feat.
A. Kasi
05:53
2021 KUMC Virtual Multidisciplinary Oncology Review
mCRC Updates: FOLFOXIRI+Bev for Unresectable Disease, CEND-1+Neoadju…
Feat.
A. Kasi
09:37
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates on dMMR/MSI-H CRC: Survival Data for Pembro & Nivo, Fron…
Feat.
H. Lenz
06:58
2021 KUMC Virtual Multidisciplinary Oncology Review
IO Updates for MSS & HER2 Overexpression CRC: Nivo Alone or in C…
Feat.
H. Lenz
16:09
2021 KUMC Virtual Multidisciplinary Oncology Review
RAS/RAF Mutations and New Approaches in CRC: Onvansertib+Irinotecan …
Feat.
H. Lenz
12:11
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates in Esophageal & GEJ Cancers: Preoperative CRT in EC, Pem…
Feat.
D. Akhavan
20:22
2021 KUMC Virtual Multidisciplinary Oncology Review
Esophagectomy vs. Total Gastrectomy for GEJ Adenocarcinoma: Pros and…
Feat.
M. Al-Kasspooles
18:33
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 RT Updates in Localized, Post-Operative, and Oligometastatic PC…
Feat.
X. Shen
17:00
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Updates in Surgical Treatment of PC: Diagnosis, MRI in Biopsy, …
Feat.
W. Parker
08:24
2021 KUMC Virtual Multidisciplinary Oncology Review
KUMC Updates on PFS/OS Data in mHSPC: Enzalutamide or Standard 1L Th…
Feat.
R. Parikh
14:33
2021 KUMC Virtual Multidisciplinary Oncology Review
KUMC Updated Data on mCRPC: Cabazitaxel vs. Abiraterone/Enzalutamide…
Feat.
R. Parikh
